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Abstract  Transjugular  liver  biopsy  is  a  safe,  effective  and  well-tolerated  technique  to  obtain
liver  tissue  specimens  in  patients  with  diffuse  liver  disease  associated  with  severe  coagu-
lopathies  or  massive  ascites.  Transjugular  liver  biopsy  is  almost  always  feasible.  The  use  of
ultrasonographic  guidance  for  percutaneous  puncture  of  the  right  internal  jugular  vein  is  rec-
ommended  to  decrease  the  incidence  of  local  cervical  minor  complications.  Semiautomated
biopsy devices  are  very  effective  in  obtaining  optimal  tissue  samples  for  a  precise  and  def-
inite  histological  diagnosis  with  a  very  low  rate  of  complication.  The  relative  limitations  of
transjugular  liver  biopsy  are  the  cost,  the  radiation  dose  given  to  the  patient,  the  increased
procedure  time  by  comparison  with  the  more  common  percutaneous  liver  biopsy,  and  the  need
of  a  well-trained  interventional  radiologist.
©  2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Transjugular  liver  biopsy  is  a  well-established  technique  for  obtaining  histological
samples  from  patients  with  acute  or  chronic  liver  disease  who  have  severe  coagulation
abnormalities  or  ascites  [1,2].  Although  it  requires  a  longer  procedure  time,  an  experi-
enced  interventional  radiologist,  and  costs  more  than  percutaneous  biopsy,  transjugular
liver  biopsy  is  necessary  in  many  circumstances  to  permit  histological  analysis  of  the  liver
parenchyma,  which  is  the  key  examination  for  diagnosis  and  management  of  many  hepatic
diseases  [3].  For  patients  with  severe  coagulation  abnormalities  or  ascites,  standard  per-
cutaneous  liver  biopsy  is  associated  with  a  high  risk  of  hemoperitoneum,  which  can  be
life  threatening  [1,4].  To  avoid  these  risks,  transjugular  biopsy  is  a  satisfactory  alternate
option,  and  is  better  tolerated  by  patients  [3,5].  The  sample  collection  technique  using  a
semiautomated  system  has  been  adopted  by  almost  all  interventional  radiologists.
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The  aim  of  this  minireview  is  to  recall  the  indications  and
ontraindications for  transjugular  liver  biopsy,  to  propose
 rigorous  technique  for  performing  it  and  to  analyze  the
esults reported  in  the  literature  according  to  the  biopsy
ystem used.
ndications and contraindications
ndications
ransjugular  liver  biopsy  is  used  to  obtain  samples  of  liver
issue in  diffuse  liver  disease  associated  with  a  severe
oagulation disorder,  ascites  or  a  combination  of  the  two
onditions [1].  Liver  biopsies  are  necessary  for  diagnos-
ng cirrhosis,  acute  liver  failure,  or  viral  hepatitis,  and  for
ssessing its  activity,  for  determining  whether  there  is  non-
lcoholic  steatohepatitis  (NASH),  or,  in  fulminant  hepatitis,
or determining  the  prognosis  and  providing  the  indica-
ion for  an  emergency  liver  transplant  [4,6].  At  present,
he main  indication  for  transjugular  liver  biopsy  is  diag-
osis of  acute  alcoholic  hepatitis,  due  to  the  need  for
peciﬁc corticosteroid  treatment  and  the  frequency  of
emostatic disorders  in  this  condition  [7].  Similarly,  just
fter a  liver  transplant,  hemostatic  disorders  are  com-
on, so  that  a  histological  examination  is  often  necessary
8].
Biopsy via  the  venous  system  reduces  the  risks  of  bleed-
ng, because  the  capsule  of  Glisson  is  not  perforated  [9,10].
n addition,  if  bleeding  does  occur,  it  returns  directly  into
he venous  system  rather  than  into  the  peritoneum.  Indi-
ations for  transjugular  liver  biopsy  in  general  result  from
ontraindications to  percutaneous  biopsy  and  include  a
rothrombin level  lower  than  50  or  60%  of  normal  val-
es depending  on  local  policies,  a  platelet  count  of  less
han 60,000/mL,  abundant  ascites,  the  need  to  measure
he pressures  in  the  hepatic  vein,  right  atria  and  inferior
ena cava  as  well  as  the  intraportal  pressure  (wedge  or
recapillary pressure),  or  an  anticoagulant  or  antiplatelet
ggregation treatment  that  cannot  be  interrupted  [4].  Some
uthors include  other  indications  even  if  there  is  no  coag-
lation abnormality  or  ascites,  such  as  previously  failed
ercutaneous biopsy,  morbid  obesity,  an  atrophic  liver,
uspected amyloidosis,  a  cardiac  liver,  hemodialysis  and
hronic renal  insufﬁciency,  peliosis  hepatis,  and  hereditary
emorrhagic telangiectasia,  which  all  increase  the  risk  of
emorrhage [4,11].
ontraindications
ransjugular  liver  biopsy  is  generally  contraindicated  or  not
easible  if  there  is  thrombosis  of  the  right  internal  jugular
ein [4].  But  in  this  case,  there  are  alternative  approaches,
uggested by  certain  authors  such  as  via  the  right  external
ugular vein,  the  left  internal  jugular  vein  or  the  femoral
ein. However,  these  approaches  are  more  risky  than  the
onventional route  and  should  be  performed  by  very  expe-
ienced interventional  radiologists  and  used  only  as  a  last
esort.
The other  contraindications  for  transjugular  liver  biopsy
re thrombosis  of  the  hepatic  veins,  hydatid  cyst,
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holangitis,  and  the  absence  of  cooperation  from  the  patient
4].
aterial and technique
reparation
he  patient  receives  a  premedication  of  100  mg  hydrox-
zine (Atarax®, UCB  Pharma  SA)  orally  and,  depending  on
he team,  1  g  of  paracetamol  codeine  (Dafalgan  codeine®,
ristol-Myers Squibb)  two  hours  before  the  procedure.  An
mlapatch® 5%  (AstraZeneca)  is  routinely  applied  to  the
uncture site  on  the  neck  one  hour  before  the  procedure.
uring the  biopsy,  which  is  performed  in  an  interven-
ional radiology  room,  under  strictly  aseptic  conditions,  the
atient’s vital  signs  are  checked  by  repeatedly  recording
rterial pressure  and  continuous  heart  monitoring  to  detect
rrhythmia as  the  catheter  passes  through  the  right  atria
12]. The  patient  is  infused  into  an  antecubital  vein  into  the
ight arm.  The  classic  recommendation  is  that  the  patient
hould have  strictly  fasted  so  that  general  anesthesia  can  be
dministered in  the  unlikely  event  of  the  need  for  surgical
anagement of  a  severe  complication  of  the  biopsy.
uncture procedure
ransjugular  liver  biopsy  is  performed  by  an  experienced
nterventional radiologist  assisted  by  a  radiology  technician.
he French  Health  Authority’s  (HAS)  generic  interventional
adiology checklist  should  be  used.  It  is  accessible  from  the
ollowing link  (in  French,  accessed  15  April  2013):  http://
ﬁcv-com.micrologiciel.com/images/ﬁles/Check  list  Rx
erniere  version  relu  DF.pdf.
Ultrasonographic  localization  of  the  right  internal  jugu-
ar vein  and  real-time  guidance  of  the  puncture  process
s highly  recommended  to  increase  safety  [13].  Ultra-
onographic guidance  avoids  accidental  puncture  of  the
psilateral carotid  artery  and  pneumothorax,  and  allows  the
ost suitable  puncture  point  to  be  chosen,  depending  on
he individual  anatomy,  with  negligible  increase  in  the  pro-
edure time  [14].  It  is  essential  in  patients  with  a  short
eck. Ultrasonography  also  ensures  that  the  right  internal
ugular vein  is  patent  [13,14].  When  the  jugular  vein  is  of
mall diameter  or  is  collapsed,  it  is  possible  to  distend  it  by
arefully tilting  the  angiography  table  to  lift  the  patient’s
eet and  increase  the  cardiac  preload  or,  more  rarely,  to
ncrease the  blood  volume  by  intravenous  administration
f saline  depending  on  the  hemodynamic  and  cardiac  sta-
us. The  skin  of  the  neck  over  the  selected  entry  site  is
terilely cleansed  using  a  local  antiseptic  and  a  preperfo-
ated sterile  drape  is  used  to  cover  the  patient.  A  local
nesthetic agent  (2%  lidocaine)  is  used  to  numb  the  skin.
 small  skin  incision  is  made  with  a  disposable  scalpel
lade, then  the  right  internal  jugular  vein  is  punctured
sing an  18-Gauge  needle-catheter  under  ultrasonographic
uidance using  a  superﬁcial  high-frequency  linear  probe
raped in  a dedicated  sterile  covering  and  sterile  ultrasono-
raphic gel.  After  introducing  a  0.035-inch  J-tipped  guide
ire, a  9-French  10  cm  long  introducer  sheath  is  inserted
ccording to  Seldinger’s  technique.  The  right  hepatic  vein
s catheterized  with  a  5-French  end-hole  catheter  and
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[Transjugular  liver  biopsy:  Indications,  technique  and  results
a  J-tipped  0.035  inch  ﬂexible  hydrophilic  guide.  Fluoro-
scopic angiography  is  used  to  ensure  that  the  catheter  is
correctly in  place  in  the  right  hepatic  vein,  using  10  mL
of iodinated  contrast  agent  injected  by  hand.  A  145  cm
long 0.035  inch  stiff  guide  (Amplatz  extra-stiff,  Cook  or
other) is  then  introduced  into  the  5-French  catheter  allow-
ing an  exchange  and  the  introduction  of  the  7-French
curved-end sheathing  catheter  [13].  To  assist  with  this
introduction, the  patient  is  asked  to  breathe  in  deeply
and to  hold  his  or  her  breath.  This  step  is  important
because it  opens  the  angle  between  the  inferior  vena  cava
and the  right  hepatic  vein,  making  the  procedure  easier
(Fig. 1).  After  withdrawing  the  stiff  guide  wire,  the  samp-
ling system  is  introduced  coaxially  to  carry  out  the  biopsy
[13].
The procedure  is  checked  regularly  by  moderate  use  of
ﬂuoroscopy. It  is  important  to  ensure  that  the  distal  end
of the  biopsy  needle  is  not  too  close  to  the  liver  capsule,
because during  the  biopsy  the  semiautomatic  sampling  sys-
tem moves  forward  by  at  least  24  mm  [15,16].  For  this
reason, to  better  control  the  distance  between  the  liver  cap-
sule and  the  distal  tip  of  the  biopsy  needle,  it  is  preferable
to use  the  right  hepatic  vein.  In  the  case  of  ascites,  the  exact
situation of  the  liver  capsule  is  estimated  by  prior  abdomi-
nal ultrasonography  or  CT  examination.  Following  each  pass,
some authors  recommend  opaciﬁcation  of  the  hepatic  vein
to detect  any  break  in  the  capsule  and  leakage  of  contrast
agent. It  is  recommended  to  take  three  biopsy  samples,  but
two passes  seem  to  be  sufﬁcient  [12,15,17,18].  The  choice
between two  or  three  passes  must  be  left  to  the  interven-
tional radiologist’s  judgment,  depending  on  the  total  size
of the  ﬁrst  two  samples  and  their  degrees  of  fragmenta-
tion.
Figure 1. Transjugular liver biopsy. The sheathing catheter
(arrow) is in the right hepatic vein. The angle between the infe-
rior  vena cava and the right hepatic vein is superior to 90◦, which
makes  the procedure easier.
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Once  a tissue  sample  is  obtained,  it  is  examined  visu-
lly by  the  radiologist  to  decide  whether  to  obtain  another
ne. A  sample  which  is  at  least  10  mm  long  is  essen-
ial [15,16].  The  samples  are  then  usually  ﬁxed  in  10%
ormol for  later  analysis.  They  are  subsequently  set  in
arafﬁn and  sliced  with  a  microtome  at  three  levels.
everal staining  methods  are  systematically  used  includ-
ng hematoxylin-eosin  safran,  Masson’s  trichrome  or  Sirius
ed, and  Perls’  Prussian  blue  stain  to  estimate  iron  over-
oad [15].  Other  special  preparations,  such  as  Gordon
nd Sweet’s  stain  for  reticulin,  are  performed  on  request
epending on  the  condition  being  suspected.  A minimum
f 6  portal  triads  is  necessary  for  a diagnosis  and  to
rade the  severity  of  the  acute  or  chronic  liver  condition
8,12].
The use  of  a  Colapinto  needle  (aspiration  system)  has
een replaced  by  a  semiautomatic  system.  The  Colap-
nto needle  is  now  almost  entirely  reserved  for  creating
n intrahepatic  portosystemic  shunt  [19].  The  aspiration
ystem is  associated  with  inadequate  tissue  sampling  in
2.5% to  29%  of  the  cases  and  multiple  samples  must
e taken  [20].  On  the  other  hand,  a  semiautomatic  sys-
em enables  larger,  less  fragmented,  more  reproducible
amples to  be  obtained  [15].  In  addition,  a  single  biopsy
roduces a  quality  sample  in  72%  of  cases,  thus  reducing
he number  of  passes  and  consequently  the  dose  of  radi-
tion delivered  to  the  patient  [10,12].  Finally,  using  the
emiautomatic system  signiﬁcantly  reduces  the  mean  pro-
edure time  by  about  30%  (15.5  min  as  against  22.6  min)
20].
Two semiautomatic  systems  are  currently  commercially
vailable. At  present  only  the  Quick-Core® Biopsy  Needle
as been  studied  by  a  large  number  of  studies  (Fig.  2)  [21].
he other  system  (FlexCore® Biopsy  Needle)  has  been  the
ubject of  only  a  few  comparative  studies,  but  the  com-
arison was  in  favor  of  the  FlexCore® system  in  terms  of
ragmentation and  number  of  portal  triads  in  the  specimens
20,21].
The hepatic  pressure  gradient  is  obtained  by  measuring
he wedge  pressure  and  the  free  hepatic  venous  pressure
22]. Its  normal  value  is  less  than  5  mmHg.  This  measure-
ent necessitates  very  carefully  setting  up  the  pressure
easuring system  and  increases  the  length  of  the  pro-
edure. It  is  thus  not  systematically  undertaken  but  is
eserved for  particular  indications,  especially  as  there  are
oninvasive means  available  of  indirectly  assessing  intra-
ortal pressure.  Contrast-enhanced  ultrasound  with  CO2
icrobubbles  has  recently  appeared  as  a  promising  nonin-
asive technique  but  direct  blood  measurement  is  still  the
eference method  [23].  Direct  measurement  of  the  pres-
ure gradient  allows  the  evolution  of  intraportal  pressure
o be  assessed  after  drug  treatment,  or  the  risk  of  bleed-
ng by  rupture  of  esophageal  varices,  survival  or  the  risk  of
epatic encephalopathy  to  be  predicted  [24,25].  This  mea-
urement is  useful  for  monitoring  the  response  to  antiviral
reatment in  patients  with  chronic  hepatitis  C  virus  infection
15].onitoring
t  the  end  of  the  procedure,  the  puncture  site  should  be
ompressed manually  for  10  minutes  to  avoid  a  hematoma
14  A.  Dohan  et  al.
Figure 2. Semiautomatic transjugular liver biopsy system (Quick-Core® Biopsy Needle). The four different parts from top to bottom are:
A — the biopsy needle in the ‘‘armed’’ position, B — the white 5-French end-hole catheter used to catheterize the right hepatic vein, C —
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she blue 7-French curved-ended sheathing catheter equipped with i
ill be coaxially insered into the sheathing catheter before descen
n  the  neck.  After  the  procedure,  the  patient  should  remain
ecumbent and  is  normally  monitored  clinically  and  hemo-
ynamically for  at  least  4  hours.  There  is  no  consensus
oncerning the  length  of  monitoring;  times  vary  from  4  to
4 hours.  If  there  is  abdominal  pain  after  the  biopsy  or  a
rop in  serum  hemoglobin  level,  serum  hemoglobin  should
e measured  repeatedly  and  an  abdominal  ultrasonographic
xamination undertaken.  However,  an  abdominal  CT  scan  is
ore commonly  performed.
esults
echnical results
he  mean  time  for  the  procedure  is  41  min  (range:
5—48 min)  [5,12].  The  mean  number  of  passes  reported  in
he literature  is  2.7  [12,26].  When  using  a  Colapinto  nee-
le there  was  an  overall  failure  rate  of  between  12%  and
9%. [10,13].  In  contrast,  with  the  semiautomatic  system
he success  rate  raised  to  96.8%  and  diagnostic  samples  were
btained in  96.1%  of  cases  [20].  In  the  case  of  biopsies  from
 liver  transplant,  the  technical  success  was  similar  but  the
rocedure may  be  longer  or  more  difﬁcult  due  to  venous
nastomosis and  anatomical  changes.
The  mean  size  of  the  samples  with  a  semiautomatic  sys-
em was  12.8  mm  ±  4.5  and  the  mean  number  of  portal  triads
as 6.8  ±  2.3  [12,15].  These  values  are  signiﬁcantly  higher
han those  obtained  with  a  Colapinto  needle,  but  are  still
lightly lower  than  those  of  samples  obtained  by  percuta-
eous biopsy.  The  mean  rate  of  fragmentation  of  samples
as 34.3%  [20].  Most  medical  teams  consider  that  the  qual-
ty of  samples  obtained  via  the  transjugular  route  is  very
lose to  that  of  percutaneous  biopsies  (Fig.  3)  [3].
w
v
h
[
igure 3. Liver biopsy sample (core) obtained via the transjugular rout
tain, low magniﬁcation).tireﬂux valve, and D — the black 5-French end-hole catheter which
on a stiff metal guide-wire.
ailures
he  overall  failure  rate  was  3.2%,  mostly  due  to  the  impos-
ibility to  catheterize  the  hepatic  vein  (43%)  or  the  jugular
ein (26%)  and  for  multiple  other  causes  [13].  An  acute  angle
f less  than  90◦ between  the  axis  of  the  inferior  vena  cava
nd the  hepatic  vein  was  the  commonest  cause  of  failure
nd affected  approximately  1%  of  procedures  [12].  Unde-
ired renal  sampling  has  also  been  reported  due  to  the  biopsy
ystem being  placed  in  the  right  renal  vein  rather  than  the
epatic vein  [22].
omplications
he  overall  rate  of  complications  was  7.1%,  divided  into
inor complications  (6.5%),  major  complications  (0.6%)
nd death  (0.1%)  [2,10,12].  This  was  not  correlated  with
he number  of  samples  taken  [3].  The  complications
onsisted of  hemoperitoneum  (0.2%  of  procedures,  gen-
rally due  to  perforation  of  the  capsule  of  Glisson),
rrhythmia (0.02%)  capsule  perforation  without  hemody-
amic effect  (1.4%)  transitory  abdominal  pain  (1.6%),
imited intrahepatic  hematoma  (2%)  neck  hematoma  (0.8%)
nd  other  very  exceptional  complications  such  as  a  bil-
ary ﬁstula,  or  hepatic  artery  aneurysm  [12,27,28].  Minor
omplications such  as  neck  pain,  hematoma  in  the  neck,
ccidental puncture  of  the  carotid  artery  and  pneumoth-
rax were  much  rarer  when  ultrasonographic  guidance
as used  to  monitor  the  puncture  of  the  internal  jugular
ein [8,12].  Causes  of  mortality  were  almost  exclusively
emoperitoneum (0.06%)  and  ventricular  arrhythmia  (0.04%)
29,30].
e. The sample measures 20 mm long and is hardly fragmented (HES
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Conclusion
Transjugular  liver  biopsy  is  indicated  in  diffuse  liver  disease,
for patients  with  contraindications  to  a  standard  percu-
taneous approach.  It  is  a  relatively  simple  technique,  as
effective as  a  transparietal  biopsy,  well  tolerated  with  very
few contraindications  at  the  penalty  of  a  greater  proce-
dure time  and  extra  costs.  The  use  of  ultrasonographic
guidance to  puncture  the  internal  jugular  vein  signiﬁcantly
reduces the  incidence  of  minor  complications.  The  use  of
semiautomatic sampling  systems  substantially  increases  the
diagnostic yield  of  tissue  samples.  This  procedure  has  a  rela-
tively  low  level  of  morbidity  and  mortality  when  performed
by an  experienced  radiologist.
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